Multidisciplinary Delphi consensus-based recommendations on the use of image-guided radiotherapy for upper gastrointestinal tumours: an AIRO–AITRO–AIFM study
This national, multidisciplinary Delphi consensus provides a structured framework for defining IGRT standards in upper-GI malignancies, and confirms a shared vision and practice, supporting harmonised and precision-oriented RT delivery.
Abstract
Abstract Objectives Upper gastrointestinal (GI) malignancies represent one of the most challenging scenarios for image-guided radiotherapy (IGRT). Despite technological advances, clinical practice remains heterogeneous among centres. This national, multidisciplinary Delphi consensus, jointly promoted by AIRO, AITRO, and AIFM, aimed to harmonise IGRT implementation in upper-GI radiotherapy (RT) and define shared recommendations. Methods A two-round modified Delphi process was conducted between May and August 2025 among 20 Italian experts (radiation oncologists, medical physicists, and radiation therapists) with ≥10 years of experience in upper-GI RT. 16 key questions were organised into thematic areas. Agreement was rated using a five-point Likert scale; consensus was predefined as ≥75 %. Following Round 1, the steering committee reviewed closed-ended responses, open-ended answers, and panel feedback, and formulated 13 statements for Round 2. Results All experts completed both rounds, and consensus was achieved for all final statements. Key sources of geometric uncertainty were identified as respiratory motion, rotational setup errors, and anatomical variability. The panel supported the use of dedicated immobilisation systems and advanced imaging tools, including auto-contouring for OAR delineation. Respiratory control strategies were considered the most effective approaches, while fiducial markers were recognised as valuable tools for tumour tracking in selected cases. Daily cone-beam CT was identified as the minimum standard for treatment verification. Conclusions This national, multidisciplinary consensus provides a structured framework for defining IGRT standards in upper-GI malignancies. The high agreement levels confirm a shared vision and practice, supporting harmonised and precision-oriented RT delivery.
INTRODUCTION
In this systematic review and associated guidelines, the American Radium SocietyTM (ARS) thoracic and gastrointestinal oncology expert panels worked together to thoroughly evaluate current literature and provide treatment recommendations for best outcomes for resectable esophagus or gastroesophageal juncti...
C. Anker, Aditya Juloori, D. C. Codipilly et al.· International Journal of Rad...· 0 citations
Background Locally advanced rectal cancer (LARC) considerably impairs quality of life (QoL) and compromises prognosis. Immunotherapy induces complete responses in most patients with mismatch repair deficient/microsatellite instability-high (dMMR/MSI-h) LARC, enabling organ preservation; however, challenges include acce...
R. Hofheinz, R. García-Carbonero, F. Ciardiello et al.· ESMO gastrointestinal oncolo...· 0 citations
Modified Delphi panel provides practical guidance regarding indications, timing, choice of technique and long-term follow-up of radiotherapy in pituitary adenomas.
F. Castinetti, C. Piazzola, J. Ayuk et al.· Pituitary· 2 citations
To achieve expert consensus on structured prostate MRI criteria for gadolinium-based contrast agent (GBCA) administration and whole-body MRI (WB-MRI) escalation in the diagnostic evaluation and staging of prostate cancer (PCa). A three-round modified online Delphi survey was conducted among UK specialist prostate radio...
E. N. Onwuharine, A. Clark, M. Dimmock et al.· Insights into Imaging· 0 citations
The data demonstrate that the integration of LLMs in today’s MDT workflow is feasible and may benefit the quality of decision-making in specific cases, and suggests that more advanced local models may offer safe, rapid, and cost-effective support for MDT decision-making.
C. Buhr, L. Müller, D. Pinto dos Santos et al.· JMIR AI· 0 citations
BACKGROUND
Advanced cutaneous squamous cell carcinoma (acSCC) encompasses locally advanced and metastatic disease; however, no standardized definition exists. Recognition and categorization, therefore, often rely on multidisciplinary judgment, which may lead to variations in diagnosis and management between centers. Th...
A. Challapalli, A. Durrani, G. Stewart et al.· Future Oncology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.